Semaglutide Injection 1.7 mg / 0.75 mL

Semaglutide Injection 1.7 mg / 0.75 mL is a semaglutide-based injectable formulation supplied in a pre-filled pen for subcutaneous administration.

Semaglutide belongs to the GLP-1 receptor agonist class and may be prescribed as part of a comprehensive treatment plan for eligible patients. The formulation is intended for use under the direction and supervision of a qualified healthcare professional.

Farlex Semaglutide Injection 1.7 mg / 0.75 mL is presented in a convenient pre-filled pen format for professional pharmaceutical use and administration as prescribed.

Composition: Semaglutide Injection 1.7 mg / 0.75 mL
Packing: 1 Pre-filled Pen
Route of Administration: Subcutaneous